The goal of this clinical trial is to learn if topical crisaborole ointment works to treat vitiligo. It will also learn about the safety of the drug. The main questions it aims to answer are:

Can the drug cause repigmentation of vitiligo lesions when used as topical form after microneedling? What medical problems do participants have when the drug used?

Participants will:

Visit the clinic once every 2 weeks to have the microneedling sessions for 3 months. and also they will have narrow band UVB sessions two times per week.

Record any side effect they have during or after the sessions.

Inclusion Criteria:

• Patients suffer from non-segmental stable vitiligo.
• Patients who will accept to be included in the study and will sign a written consent.

Exclusion Criteria:

• Patients with history of koebnerization or any sign of disease activity.
• Patients with keloid tendency.
• Patients with active infection.
• Pregnant or lactating woman.